[Very old patients in multidisciplinary team meeting in PACA: a one-year survey].
Patients très âgés dans les RCP en région PACA : observation sur une année.
Age Distribution
Aged, 80 and over
Breast Neoplasms
/ epidemiology
Comorbidity
Digestive System Neoplasms
/ epidemiology
Female
France
/ epidemiology
Health Transition
Humans
Lung Neoplasms
/ epidemiology
Male
Neoplasms
/ epidemiology
Patient Care Team
Prostatic Neoplasms
/ epidemiology
Sex Distribution
Geriatric oncology
Multidisciplinary team meeting
Oncogétriatrie
Patients très âgés
Réunion de concertation pluridisciplinaire
Very old patients
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
10
01
2021
revised:
02
05
2021
accepted:
21
05
2021
pubmed:
26
9
2021
medline:
19
11
2021
entrez:
25
9
2021
Statut:
ppublish
Résumé
In 2011, 11% of all cancers were diagnosed in people over 85 years old. With the current aging of the French population associated with health progress, we will be confronted more and more frequently with the treatment of very old patients, and this until the horizon 2050, when the population over 75 years old will represent approximately 15% of the total French population (compared to 9.1% in 2015). To understand the management methods for patients over 85 years old with cancer, we carried out an observational study, based on data collected in the OncoPACA-Corse network, with the objective to describe the demographic data of very elderly patients, the characteristics of their pathology and to analyze the therapeutic strategies proposed by oncologists to patients in this population. One thousand three hundred and fifty five cases were analyzed. The mean age of the patients was 88.9 years with 3% of patients over 95 years old and only one was over 100 years old. 51.6% were women. Digestive tumors were the most represented (23.4%), followed by breast tumors (17.7%) and prostate tumors (10.5%), with a diagnosis made at a metastatic stage in 20% of cases. We note that treatment was offered for nearly 85% of patients with a wide range of options, exclusive palliative care was offered in 15% of cases; and whena treatment considered to be not very aggressive, such as hormone therapy, was offered, it seems to be preferred as monotherapy.
Identifiants
pubmed: 34561024
pii: S0007-4551(21)00305-2
doi: 10.1016/j.bulcan.2021.05.011
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
fre
Sous-ensembles de citation
IM
Pagination
1036-1043Informations de copyright
Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.